Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
PuraPharm Corp. Ltd. ( (HK:1498) ) just unveiled an update.
PuraPharm Corporation Limited has announced its upcoming Annual General Meeting scheduled for May 27, 2025, in Hong Kong. Key agenda items include the adoption of the 2024 financial statements, re-election of directors, re-appointment of the auditor, and a proposal for a share buyback mandate. These resolutions aim to strengthen corporate governance and potentially enhance shareholder value.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited operates in the pharmaceutical industry, focusing on the development and production of Chinese medicine products. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -11.82%
Average Trading Volume: 127,300
Technical Sentiment Signal: Buy
Current Market Cap: HK$191.5M
See more data about 1498 stock on TipRanks’ Stock Analysis page.